Answers are grounded in this paper and cite their sources.
Retrospective analysis shows PATENTS increases erectile function recovery in patients after robotic-assisted surgeries, indicating better outcomes with lower risk of adverse events.
Background and Objective: A posterior approach to endopelvic neurovascular total sparing (PATENTS) during robotic-assisted radical prostatectomy (RARP) may improve recovery of sexual function through preservation of anterolateral periprostatic tissue. We compared RARP erectile function recovery with PATENTS vs the conventional anterior nerve-sparing approach. Methods: We conducted a single surgeon retrospective review of 495 RARP (278 anterior nerve-sparing, 217 PATENTS) performed during 2015 to 2025, with initiation of PATENTS in 2022. Our primary outcome was erectile function recovery defined as erections sufficient for sexual activity (at least masturbation/foreplay) from the Expanded Prostate Cancer Index Composite for Clinical Practice (EPIC-CP). Cox proportional hazard models evaluated factors affecting recovery of erectile function. Key Findings and Limitations: PATENTS patients were older (median 66 vs 64 years; P = .002) and more likely to have clinically significant cancer at diagnosis (95.8% vs 86.0%; P = .003). Despite shorter follow-up (5 months [IQR 3-15] vs 10 [3-21], P < .001), PATENTS was associated with shorter duration to erections sufficient for intercourse ( P = .022). In adjusted analyses, PATENTS was associated with improved erections firm enough for intercourse (hazard ratio [HR] 2.3, confidence interval [CI]: 1.45-3.68, P < .001), erections firm enough for sexual activity (HR 1.5, CI: 1.21-1.96, P < .001), and any partial erections (HR 1.4, CI: 1.13-1.63, P < .001). There were no differences in margin status ( P = .234) or adverse events ( P = .933). Study limitations include single surgeon, retrospective study design. Conclusions and Clinical Implications: PATENTS facilitated recovery of erectile function without compromising surgical margins or adverse events. Prospective, multisurgeon series are needed to validate our findings.
No takes yet. Share an insight, caveat, or question.
Wald et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: